Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.

"Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Dr. Cong is an employee of Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). Drs. Milling, Fromm, Ganetsky, Pallin, and Singer report that they received financial support from BIPI to cover administrative costs and costs of data collection for this study. Drs. Milling and Ganetsky also report grants or other support from BIPI outside the submitted work."

"Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org ). Dr. Cong is an employee of Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). Drs. Milling, Fromm, Ganetsky, Pallin, and Singer report that they received financial support from BIPI to cover administrative costs and costs of data collection for this study. Drs. Milling and Ganetsky also report grants or other support from BIPI outside the submitted work."

"Trial registration number: NCT02149303"